UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Devex features a sponsored interview with Dennis Broun, executive director of UNITAID, which uses innovative financing and "its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income countries." Broun discusses innovations in global health financing, lessons from UNITAID for the global health community, and solutions to overcoming obstacles to entering markets, ensuring supply chains, and improving access, according to the news service. "We are faced with problems of intellectual property, for instance; this is why we have set up what is called the Medicines Patent Pool to help arrange voluntary licenses for HIV drugs, as patents can block access," Broun notes, according to Devex (Rosenkrantz, 4/23). The Center for Global Health Policy's "Science Speaks" blog highlights a presentation given last week at the Global AIDS Policy Partnership meeting by Medicines Patent Pool Executive Director Greg Perry (Aziz, 4/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI outperforms doctors in diagnostics but falls short as a clinical assistant